2016
DOI: 10.1007/s40273-016-0439-3
|View full text |Cite
|
Sign up to set email alerts
|

Cost Effectiveness of Pneumococcal Vaccination in Children in Low- and Middle-Income Countries: A Systematic Review

Abstract: Our review demonstrated that an infant PCV programme was a cost-effective intervention in most LMICs (in 20 of 22 studies included). The results were sensitive to vaccine efficacy, price, burden of disease and sponsorship. Decision makers should consider EE findings and affordability before adoption of PCVs.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
37
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 49 publications
(41 citation statements)
references
References 55 publications
3
37
0
Order By: Relevance
“…Central to the success on full coverage of immunization is rooted at modifying how their parents think about the efficacy of the vaccines and the need for immunization, i.e., parental behavior intention. 6,7 Previous studies have identified potential barriers to increasing the child's immunization rates, including: vaccination costs, vaccine knowledge or misconceptions, distance and waiting time for vaccination, and vaccine acceptance among children and parents. [7][8][9][10] Strategies have been proposed to reduce these barriers, including reducing the family's vaccination expenditures, enhancing parents' knowledge and attitudes towards children's vaccination, and eliminating vaccine allergies.…”
Section: Introductionmentioning
confidence: 99%
“…Central to the success on full coverage of immunization is rooted at modifying how their parents think about the efficacy of the vaccines and the need for immunization, i.e., parental behavior intention. 6,7 Previous studies have identified potential barriers to increasing the child's immunization rates, including: vaccination costs, vaccine knowledge or misconceptions, distance and waiting time for vaccination, and vaccine acceptance among children and parents. [7][8][9][10] Strategies have been proposed to reduce these barriers, including reducing the family's vaccination expenditures, enhancing parents' knowledge and attitudes towards children's vaccination, and eliminating vaccine allergies.…”
Section: Introductionmentioning
confidence: 99%
“…35 By reducing the carriage of S. pneumoniae and transmission to contacts, there also has been a concordant decline in the incidence of IPD among the non-vaccinated population. 36 As other published economic have reported, 15,31 the herd effects of vaccinations have a substantial impact on the economic outcomes of PCV-13. When the herd effect was included, our model outputs found that the ICERs of a PCV-13 vaccination program Figure 2.…”
Section: Discussionmentioning
confidence: 94%
“…One recent systematic review has reported that an infant PCV vaccination program was a cost-effective strategy in most low-and middle-income countries (LMICs), including 22 economic evaluations conducted in LMICs. 31 The PCV-13 price per dose in LMICs varied from $3.50 in GAVI-eligible countries to $30 in GAVI-ineligible countries, except for Thailand (»$63) and China (»$58). Our analysis was consistent with the Thai cost-utility analysis, which showed that PCV vaccinations with PCV-10 and PCV13 are not cost-effective even when indirect vaccine effects were considered.…”
Section: Discussionmentioning
confidence: 99%
“…In the specific case of pneumococcal vaccines, the scientific evidence on safety evaluation, immunogenicity, the effect on the carrier status and dose schedules comparisons have been widely supported in literature and it based on hard designs of clinical studies involving large cohorts of vaccines and follow-up of systematic reviews and metanalysis [17][18][19][20][21][22]. For this reason, the generation of evidences of the new Cuban vaccine should be rigorous enough to ensure international comparisons and it's positioning as product in vaccine markets.…”
Section: Process Of Scientific Evidence Generationmentioning
confidence: 99%
“…Cots-effectiveness systematic review qbout Pneumococcal Vaccination in Children in Low-and Middle-Income Countries[22]. It s demonstrated that an infant PCV programme was a cost-effective intervention in most LMICs (in 20 of 22 studies included).…”
mentioning
confidence: 99%